New enrollments will be accepted until June 15, 2023. Course MUST be completed by July 1, 2023.
Release date: 5/17/2021
Expiration date: 7/1/2023
Target Audience
This activity is designed to meet the needs of physicians, physician assistants, nurses and other healthcare professionals.
Learning Objectives
Upon completion of the educational activity, participants should be able to:
- Identify the sources of electromagnetic pollution
- List the characteristics of the spectrum that have biological significance (i.e. frequency, modulation, wave form, pulsing, units of measurement, windows effects, duty cycle, etc)
- Recognize and diagnose someone with an EMF associated illness, determine what precautionary advice to offer patients, or refer patients to an EMF Assessment Professional who will advise patients on ways to reduce or eliminate EMF exposure risks
- Discuss frequency therapy techniques used to deal with chronic health problems that are successfully used around the world but poorly understood in North America
Method of Participation
In order to receive credit, participants should watch all videos, successfully complete the quiz and submit the evaluation. The passing score for the quiz is 70%. A certificate will be available upon successful completion of all course elements. If you have questions about this CME/CE activity, please contact AKH Inc. at [email protected].
CME/CE credit provided by AKH Inc., Advancing Knowledge in Healthcare. This activity is jointly-provided by AKH Inc., Advancing Knowledge in Healthcare and The Electromagnetic Safety Alliance, Inc.
In support of improving patient care, this activity has been planned and implemented by AKH Inc., Advancing Knowledge in Healthcare and The Electromagnetic Safety Alliance, Inc. AKH Inc., Advancing Knowledge in Healthcare is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Physicians
AKH Inc., Advancing Knowledge in Healthcare designates this enduring material for a maximum of 4.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity
Nurses
Credit being awarded: 4.0 ANCC contact hours
Physician Assistants
AKH Inc., Advancing Knowledge in Healthcare has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 4.0 AAPA Category 1 CME credits. Approval is valid until 7/1/2023. PAs should only claim credit commensurate with the extent of their participation.
| DISCLOSURES | ||
| Name | Relationship | Commercial Interest |
| Magda Havas, PhD (faculty) | N/A | Nothing to Disclose |
| Dorothy Caputo, MA, BSN, RN, CE Director of Accreditations/Lead Nurse Planner | N/A | Nothing to disclose |
| AKH Inc., Advancing Knowledge in Healthcare Staff and Planners | N/A | Nothing to disclose |
| The Electromagnetic Safety Alliance, Inc. Staff and Planners | N/A | Nothing to disclose |
| All of the relevant financial relationships listed for these individuals have been mitigated. |
Commercial Support
There is no commercial support for this activity.
Disclosures
It is the policy of AKH Inc. to ensure independence, balance, objectivity, scientific rigor, and integrity in all of its continuing education activities. The planners and faculty must disclose to the participants any significant relationships with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.” or with the commercial supporter of this accredited continuing education activity. Identified conflicts of interest are mitigated by AKH prior to the planners/faculty assuming their role in this accredited continuing education activity.
Disclosure of Unlabeled Use and Investigational Product
This educational activity may include discussion of uses of agents that are investigational and/or unapproved by the FDA. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Disclaimer
This course is designed solely to provide the healthcare professional with information to assist in his/her practice and professional development and is not to be considered a diagnostic tool to replace professional advice or treatment. The course serves as a general guide to the healthcare professional, and therefore, cannot be considered as giving legal, nursing, medical, or other professional advice in specific cases. AKH Inc. specifically disclaims responsibility for any adverse consequences resulting directly or indirectly from information in the course, for undetected error, or through participant’s misunderstanding of the content.
